fashion -WSS

fashion

author：Wikipedia 2025-09-27 19:37:03 - browse：3

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Obesity drugs seen as possible treatment for liver disease MASH

WSS

STAT readers on older presidents, polypills, Medicare, and more

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

NIH study of ME/CFS points to clear biological hallmarks

Doctors have an ethical obligation to be advocates

In utero gene editing: an explainer

knowledge

fashion

Wikipedia

Moonlake's readout produced a cash windfall. Risks remain

New documents shed light on MD Anderson Cancer Institute feud

Sports medicine is finally prioritizing gender equality

Transgender women dream of pregnancy via uterus transplants

After affirmative action ruling, medical educators look to 'holistic review'

Malaysia cuts short music fest after British band slams anti

The cancer drug shortage isn’t new — and neither are the solutions

PBM reform efforts get punted in Congress

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

leisure time

6 phony surgeries that take placebo to the extreme

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Dario to buy mental health app maker Twill in cash and stock deal

A new nitrogen execution bill also undermines medical licensing

Where does female orgasm come from? Scientists think they know

entertainment

focus

hotspot

hotspot